A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
Clinical trial NCT05697055 · UNKNOWN
Trial details
- NCT number
- NCT05697055
- Sponsor
- Shandong Provincial Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-21
- Primary completion
- 2023-05-21
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.